|
Clifford Lu, MD, PhD
|
Clifford is currently a fourth year MD/PhD candidate at the Icahn School of Medicine at Mount Sinai in the Development, Regeneration, and Stem Cells training area. His doctoral thesis work is focused on understanding the molecular mechanisms of RASopathy associated hypertrophic cardiomyopathy and congenital heart defects, utilizing induced pluripotent stem cells as a disease model. Prior to medical school, he completed his master’s and undergraduate degrees at UC San Diego in a neuropharmacology lab, where he studied the regulation of nicotinic acetylcholine receptors by various chaperone and auxiliary proteins.
Clifford is passionate about improving the lives of patients and advancing the field of medicine. He is especially intrigued with how innovations in technology and AI can transform our approach to patient care and accelerate biomedical discoveries. He is excited to work with new companies in this space while learning about venture capital investing. In addition to his medical and venture capital interests, Clifford enjoys working out, listening to podcasts, and reading nonfiction books.
Clifford is passionate about improving the lives of patients and advancing the field of medicine. He is especially intrigued with how innovations in technology and AI can transform our approach to patient care and accelerate biomedical discoveries. He is excited to work with new companies in this space while learning about venture capital investing. In addition to his medical and venture capital interests, Clifford enjoys working out, listening to podcasts, and reading nonfiction books.
